Efficacy and Safety of Tolvaptan in the Treatment of Cardiac-Induced Edema in Patients With Heart Failure

NCT01618448 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

85

Enrollment

INDUSTRY

Sponsor class

Conditions

Cardiac-induced Edema

Interventions

DRUG: Tolvaptan
DRUG: Placebo

Sponsor

Taiwan Otsuka Pharm. Co., Ltd